ALDR - Alder BioPharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-1,619113-
Cost of Revenue161,994190,30188,46443,036
Gross Profit-161,994-188,682-88,351-43,036
Operating Expenses
Research Development77,11464,22044,40926,575
Selling General and Administrative47,47438,10226,14816,718
Non Recurring----
Others----
Total Operating Expenses286,582292,623159,02186,329
Operating Income or Loss-286,582-291,004-158,908-86,329
Income from Continuing Operations
Total Other Income/Expenses Net-9,8472,1252,654859
Earnings Before Interest and Taxes-286,582-291,004-158,908-86,329
Interest Expense-17,185-17,185-17,185-17,185
Income Before Tax-296,429-288,879-156,254-85,470
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-296,429-288,879-156,254-85,470
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-296,429-288,879-156,254-85,470
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-331,934-288,879-156,254-85,470